Literature DB >> 17034587

Glomerular expression and elevated serum Bcl-2 and Fas proteins in lupus nephritis: preliminary findings.

N A Fathi1, M R Hussein, H I Hassan, E Mosad, H Galal, N A Afifi.   

Abstract

Programmed cell death (apoptosis) is involved in glomerular injuries leading to glomerulonephritis. Bcl-2 and Fas are proteins that promote cell survival and death, respectively. This study tests the hypothesis that lupus nephritis is associated with alterations of Bcl-2 and Fas protein expression. Thirty-six patients with lupus nephritis and 10 controls (normal individuals) were included in this study. Bcl-2 and Fas positive cells were examined in kidney biopsies by immunohistochemistry. Bcl-2 and Fas serum levels were evaluated by enzyme-linked immunosorbent assay (ELISA). In the glomeruli of normal kidneys, Bcl-2 and Fas proteins were completely absent. In lupus nephritis patients, glomerular expression of Bcl-2 and Fas was seen in mesangial cells (1.3 +/- 0.1 and 2.0 +/- 0.1 for Bcl-2 and Fas, respectively). Similarly, a statistically significantly higher Bcl-2 (217.1 +/- 85.9) and Fas (767.9 +/- 271) serum levels were found in lupus patients compared to controls (148.6 +/- 87, 550.3 +/- 91 for Bcl-2 and Fas, P < 0.05). A direct correlation between serum Bcl-2 and Fas and chronicity index was also found. Compared to normal controls, lupus nephritis is associated with glomerular expression and elevated serum levels of Bcl-2 and Fas proteins. These findings suggest possible roles for Bcl-2 and Fas in glomerular injury during evolution of lupus nephritis. The diagnostic, prognostic and therapeutic ramifications of our findings are open to further investigation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17034587      PMCID: PMC1942057          DOI: 10.1111/j.1365-2249.2006.03219.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  20 in total

1.  Relationship of oncogenes (sFas, Bcl-2) and cytokines (IL-10, alfa-TNF) with the activity of systemic lupus erythematosus.

Authors:  C Miret; J Font; R Molina; M Garcia-Carrasco; X Filella; M Ramos; R Cervera; A Ballesta; M Ingelmo
Journal:  Anticancer Res       Date:  2001 Jul-Aug       Impact factor: 2.480

Review 2.  Immunopathogenesis of lupus and lupus nephritis: recent insights.

Authors:  Reshma Kewalramani; Ajay K Singh
Journal:  Curr Opin Nephrol Hypertens       Date:  2002-05       Impact factor: 2.894

3.  Fas-Fas ligand system in the peripheral blood of patients with renal diseases.

Authors:  M Sato; T Konuma; N Yanagisawa; H Haizuka; H Asakura; Y Nakashima
Journal:  Nephron       Date:  2000-06       Impact factor: 2.847

4.  [Serum level and urinary excretion of soluble Fas (sFas) in patients with primary glomerulopathies].

Authors:  Feliks Kacprzyk
Journal:  Pol Arch Med Wewn       Date:  2002-09

5.  Analysis of apoptotic cell death, Bcl-2, and p53 protein expression in freshly fixed and cryopreserved ovarian tissue after exposure to warm ischemia.

Authors:  Mahmoud R Hussein; Mohamed A Bedaiwy; Tommaso Falcone
Journal:  Fertil Steril       Date:  2006-04       Impact factor: 7.329

6.  A shift in the Bax/Bcl-2 balance may activate caspase-3 and modulate apoptosis in experimental glomerulonephritis.

Authors:  Bin Yang; Timothy S Johnson; Graham L Thomas; Philip F Watson; Bart Wagner; Peter N Furness; A Meguid El Nahas
Journal:  Kidney Int       Date:  2002-10       Impact factor: 10.612

Review 7.  Apoptosis and melanoma: molecular mechanisms.

Authors:  Mahmoud R Hussein; Anna K Haemel; Gary S Wood
Journal:  J Pathol       Date:  2003-03       Impact factor: 7.996

8.  High levels of bcl-2 protein in circulating T lymphocytes, but not B lymphocytes, of patients with systemic lupus erythematosus.

Authors:  M Aringer; W Wintersberger; C W Steiner; H Kiener; E Presterl; U Jaeger; J S Smolen; W B Graninger
Journal:  Arthritis Rheum       Date:  1994-10

9.  Expression and function of Fas antigen and bcl-2 in human systemic lupus erythematosus lymphocytes.

Authors:  S Ohsako; M Hara; M Harigai; C Fukasawa; S Kashiwazaki
Journal:  Clin Immunol Immunopathol       Date:  1994-10

Review 10.  Bcl-2 and Fas, molecules which influence apoptosis. A possible role in systemic lupus erythematosus?

Authors:  L M Rose; D S Latchman; D A Isenberg
Journal:  Autoimmunity       Date:  1994       Impact factor: 2.815

View more
  13 in total

1.  Bcl-2 as a Therapeutic Target in Human Tubulointerstitial Inflammation.

Authors:  Kichul Ko; Jianing Wang; Stuart Perper; Yulei Jiang; Denisse Yanez; Natalya Kaverina; Junting Ai; Vladimir M Liarski; Anthony Chang; Yahui Peng; Li Lan; Susan Westmoreland; Lisa Olson; Maryellen L Giger; Li Chun Wang; Marcus R Clark
Journal:  Arthritis Rheumatol       Date:  2016-11       Impact factor: 10.995

2.  Carbon monoxide inhibits T cell activation in target organs during systemic lupus erythematosus.

Authors:  J P Mackern-Oberti; J Obreque; G P Méndez; C Llanos; A M Kalergis
Journal:  Clin Exp Immunol       Date:  2015-07-07       Impact factor: 4.330

Review 3.  Systemic lupus erythematosus after thymectomy for myasthenia gravis: a case report and review of the literature.

Authors:  Hyder A Omar; Mohammed A Alzahrani; Ali A A Al Bshabshe; Alhussain Assiri; Medhat Shalaby; Ahmad Dwedar; Saad Rezk Abdulwahed; Mahmoud Rezk-Abd-Elwahed Hussein
Journal:  Clin Exp Nephrol       Date:  2010-01-07       Impact factor: 2.801

4.  Extracellular BCL2 proteins are danger-associated molecular patterns that reduce tissue damage in murine models of ischemia-reperfusion injury.

Authors:  Akiko Iwata; Vicki Morgan-Stevenson; Barbara Schwartz; Li Liu; Joan Tupper; Xiaodong Zhu; John Harlan; Robert Winn
Journal:  PLoS One       Date:  2010-02-08       Impact factor: 3.240

5.  Fas expression on peripheral blood lymphocytes in systemic lupus erythematosus: relation to the organ damage and lymphocytes apoptosis.

Authors:  Lian-Hong Li; Wen-Xian Li; Ou Wu; Guo-Qing Zhang; Hai-Feng Pan; Xiang-Pei Li; Jian-Hua Xu; Hong Dai; Dong-Qing Ye
Journal:  Mol Biol Rep       Date:  2008-11-20       Impact factor: 2.316

Review 6.  Cell death in the pathogenesis of systemic lupus erythematosus and lupus nephritis.

Authors:  Pragnesh Mistry; Mariana J Kaplan
Journal:  Clin Immunol       Date:  2016-08-09       Impact factor: 3.969

7.  Extracellular administration of BCL2 protein reduces apoptosis and improves survival in a murine model of sepsis.

Authors:  Akiko Iwata; R Angelo de Claro; Vicki L Morgan-Stevenson; Joan C Tupper; Barbara R Schwartz; Li Liu; Xiaodong Zhu; Katherine C Jordan; Robert K Winn; John M Harlan
Journal:  PLoS One       Date:  2011-02-24       Impact factor: 3.240

Review 8.  Mesangial cell-specific antibodies are central to the pathogenesis of lupus nephritis.

Authors:  Guillaume Seret; Yannick Le Meur; Yves Renaudineau; Pierre Youinou
Journal:  Clin Dev Immunol       Date:  2011-11-28

9.  The effect of esculentoside A on lupus nephritis-prone BXSB mice.

Authors:  Hualin Ma; Xianggui Zhang; Xinzhou Zhang; Dan Yang; Lingguo Meng; Yi Zhang; Shuyan Zhou
Journal:  Arch Med Sci       Date:  2012-10-30       Impact factor: 3.318

10.  Stronger Correlation between Interleukin 18 and Soluble Fas in Lupus Nephritis Compared with Mild Lupus.

Authors:  Mohammad Reza Hatef; Maryam Sahebari; Zahra Rezaieyazdi; Mohammad Reza Nakhjavani; Mahmoud Mahmoudi
Journal:  ISRN Rheumatol       Date:  2013-03-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.